Sign In
Last checked at 
30 Apr 2024 08:10
Transaction with Affiliate Company
Β
Β
Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on April 30, 2024
announced that its Board of Directors has authorized following related-party transaction
with an affiliated company.
Β
Trademark License Agreement
- Grant trademark license to Samsung Biologics
Β
β‘ Major Transaction Terms
Transaction Item | License fee for use of trademark |
Transaction Date | May 10, 2024 |
Transaction Period | February 1, 2024-January 31, 2027 |
Transaction Value | KRW 28,244 million (total transaction value: KRW 28,244 million) |
Other information | - The transaction date is the date on which the trademark license agreement with Β Samsung Biologics will be executed. - Transaction period is the term of the trademark license agreement. - The transaction value is an estimate and may change in accordance with Β Samsung Biologics revenue. * The license fee is set at 0.5% of Samsung Biologics' revenue (excluding revenue or purchases not related to the use of trademark) and shall be paid every year during the transaction period. |
Other Information:
ΕΎ Number of Independent Directors Present at the BOD Meeting: 6/6
ΕΎ Attendance of Audit Committee: Y
Β
β» This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose
its financial and real estate transactions in the event the value of such a transaction is greater than or equal to
KRW 10 billion and the counterparty is a financial affiliate of the party required to make the disclosure.
Β
Transaction with Affiliate Company
Β
Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on April 30, 2024
announced that its Board of Directors has authorized following related-party transaction
with an affiliated company.
Β
Trademark License Agreement
- Grant trademark license to Samsung Bioepis
Β
β‘ Major Transaction Terms
Transaction Item | License fee for use of trademark |
Transaction Date | May 10, 2024 |
Transaction Period | February 1, 2024 - January 31, 2027 |
Transaction Value | KRW 12,843 million (total transaction value: KRW 12,843 million) |
Other information | - The transaction date is the date on which the trademark license agreement with Β Samsung Bioepis will be executed. - Transaction period is the term of the trademark license agreement. - The transaction value is an estimate and may change in accordance with Β Samsung Bioepis revenue. * The license fee is set at 0.5% of Samsung Bioepis' revenue (excluding revenue or purchases not related to the use of trademark) and shall be paid every year during the transaction period. |
Other Information:
ΕΎ Number of Independent Directors Present at the BOD Meeting: 6/6
ΕΎ Attendance of Audit Committee: Y
Β
β» This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose
its financial and real estate transactions in the event the value of such a transaction is greater than or equal to
KRW 10 billion and the counterparty is a financial affiliate of the party required to make the disclosure.
Follow the stocks
